Markets Rebound as Treasury Moves to Rein In Yields | The Close 8/19/2026
6 Articles
6 Articles
Markets Rebound as Treasury Moves to Rein In Yields | The Close 8/19/2026
Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are JPMorgan Private Bank Head of Alternative Investment Strategy Sitara Sundar, Ramp Co-Founder & Co-CEO Eric Glyman, D.A. Davidson Managing Director Senior Research Analyst Michael Baker, The Estée Lauder Companies President & CEO Stéphane de La Faverie, Neuberger Senior Portf…
Market returns to positive territory as Besant plan eases bond yields - Fed, inflation and Middle East concerns capped gains, however
Increased repurchases of long-term bonds led to the sharpest decline in the 30-year yield since October 2025 and gave a tailwind to stocks • Moderna jumped on results in a cancer vaccine trial, tech giants recovered • Fed minutes revealed: Committee members are considering another interest rate hike if inflation remains sticky ● Gold and oil prices record sharp increases ● Massive shorting sent Bitcoin beyond $68,000
US stocks rebounded after a sell-off in technology-focused markets. The pullback in multi-year bond yields boosted risk appetite, and positive clinical data from Moderna and Merck were in the spotlight. As of 3:50 PM GMT, the Dow Jones Industrial Average rose 119.94 points (0.22%) to 53,463.34; the S&P 500 gained 28.48 points (+0.37%) to 7,720.24; and the Nasdaq Composite advanced 67.17 points (+0.26%) to 26,356.89. Key market developments inclu…
The New York stock market opened higher today, boosted by easing bond yields ahead of the Federal Reserve meeting minutes. The Dow Jones rose 0.23%, the S&P 500 0.32%, and the Nasdaq 0.4%. The 10-year Treasury yield fell to 4.64% and the 30-year yield to 5.19% after the US Treasury increased its bond buyback operations. Oil prices rose amid uncertainty in the Middle East, while Moderna shares surged 84% following news of a cancer vaccine.
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
